Time to embrace access programmes for medicines lessons from the South African flucytosine access programme
dc.citation.doi | 10.1016/J.IJID.2020.02.057 | |
dc.citation.epage | 461 | |
dc.citation.spage | 459 | |
dc.contributor.author | A Shroufi | |
dc.contributor.author | Nelesh Govender | |
dc.contributor.author | G Meintjes | |
dc.contributor.author | John Black | |
dc.contributor.author | Jeremy Nel | |
dc.contributor.author | M Moosa | |
dc.contributor.author | Colin Menezes | |
dc.contributor.author | E et al | |
dc.date.accessioned | 2023-07-03T09:36:20Z | |
dc.date.available | 2023-07-03T09:36:20Z | |
dc.department | National Institute for Communicable Diseases (NICD) | |
dc.identifier.citation | WOS | |
dc.identifier.issn | 1201-9712 | |
dc.identifier.uri | https://hdl.handle.net/10539/35629 | |
dc.journal.title | INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | |
dc.journal.volume | 95 | |
dc.title | Time to embrace access programmes for medicines lessons from the South African flucytosine access programme |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal.pdf
- Size:
- 1.83 MB
- Format:
- Adobe Portable Document Format
- Description:
- Journal